Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 307

1.

Exploring the response of Marchantia polymorpha: Growth, morphology and chlorophyll content in the presence of anthracene.

Spinedi N, Rojas N, Storb R, Cabrera J, Aranda E, Salierno M, Svriz M, Scervino JM.

Plant Physiol Biochem. 2018 Nov 3. pii: S0981-9428(18)30488-1. doi: 10.1016/j.plaphy.2018.11.001. [Epub ahead of print]

PMID:
30429053
2.

Lysosome membrane permeabilization and disruption of mTOR-lysosome interaction are associated with the inhibition of lung cancer cell proliferation by a chloroquinoline analog.

Sironi J, Aranda E, Nordstrom LU, Schwartz EL.

Mol Pharmacol. 2018 Nov 8. pii: mol.118.113118. doi: 10.1124/mol.118.113118. [Epub ahead of print]

3.

Spontaneous Hyperventilation in Severe Traumatic Brain Injury: Incidence and Association with Poor Neurological Outcome.

Esnault P, Roubin J, Cardinale M, D'Aranda E, Montcriol A, Cungi PJ, Goutorbe P, Joubert C, Dagain A, Meaudre E.

Neurocrit Care. 2018 Nov 1. doi: 10.1007/s12028-018-0639-0. [Epub ahead of print]

PMID:
30386962
4.

Clinicopathological differences and survival outcomes with first-line therapy in patients with left-sided colon cancer and rectal cancer: Pooled analysis of 2879 patients from AGITG (MAX), COIN, FOCUS2, OPUS, CRYSTAL and COIN-B trials in the ARCAD database.

Salem ME, Yin J, Weinberg BA, Renfro LA, Pederson LD, Maughan TS, Adams RA, Van Cutsem E, Falcone A, Tebbutt NC, Seymour MT, Díaz-Rubio E, Aranda E, Bokemeyer C, Heinemann V, Wasan H, de Gramont A, Grothey A, Shi Q, Sargent DJ, Marshall JL.

Eur J Cancer. 2018 Nov;103:205-213. doi: 10.1016/j.ejca.2018.08.020. Epub 2018 Sep 27.

PMID:
30268921
5.

Purification and characterization of a fungal laccase from the ascomycete Thielavia sp. and its role in the decolorization of a recalcitrant dye.

Mtibaà R, Barriuso J, de Eugenio L, Aranda E, Belbahri L, Nasri M, Martínez MJ, Mechichi T.

Int J Biol Macromol. 2018 Dec;120(Pt B):1744-1751. doi: 10.1016/j.ijbiomac.2018.09.175. Epub 2018 Sep 27.

PMID:
30268749
6.

Validation of a monitoring matrix for patients with brain injuries.

Cardinale M, Esnault P, d'Aranda E, Meaudre E, Lacroix G.

Injury. 2018 Sep 9. pii: S0020-1383(18)30518-7. doi: 10.1016/j.injury.2018.09.016. [Epub ahead of print]

PMID:
30224177
7.

Latent tuberculosis infection is associated with increased unstimulated levels of interferon-gamma in Lima, Peru.

Huaman MA, Henson D, Rondan PL, Ticona E, Miranda G, Kryscio RJ, Mugruza R, Aranda E, Ticona C, Abarca S, Heredia P, Aguirre A, Sterling TR, Garvy BA, Fichtenbaum CJ.

PLoS One. 2018 Sep 13;13(9):e0202191. doi: 10.1371/journal.pone.0202191. eCollection 2018.

8.

Single-Agent Regorafenib in Metastatic Colorectal Cancer Patients with Any RAS or BRAF Mutation Previously Treated with FOLFOXIRI plus Bevacizumab (PREVIUM Trial).

García-Alfonso P, Benavides M, Falcó E, Muñoz A, Gómez A, Sastre J, Rivera F, Montagut C, Salgado M, López-Ladrón A, López R, Ruiz de Mena I, Durán G, Aranda E; Spanish Cooperative Group for the Treatment of Digestive Tumors (TTD).

Oncologist. 2018 Nov;23(11):1271-e128. doi: 10.1634/theoncologist.2018-0316. Epub 2018 Aug 17.

PMID:
30120161
9.

First-line mFOLFOX plus cetuximab followed by mFOLFOX plus cetuximab or single-agent cetuximab as maintenance therapy in patients with metastatic colorectal cancer: Phase II randomised MACRO2 TTD study.

Aranda E, García-Alfonso P, Benavides M, Sánchez Ruiz A, Guillén-Ponce C, Safont MJ, Alcaide J, Gómez A, López R, Manzano JL, Méndez Ureña M, Sastre J, Rivera F, Grávalos C, García T, Martín-Valadés JI, Falcó E, Navalón M, González Flores E, Ma García Tapiador A, Ma López Muñoz A, Barrajón E, Reboredo M, García Teijido P, Viudez A, Cárdenas N, Díaz-Rubio E; Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD).

Eur J Cancer. 2018 Sep;101:263-272. doi: 10.1016/j.ejca.2018.06.024. Epub 2018 Jul 24.

PMID:
30054049
10.

Schizophyllum commune: An unexploited source for lignocellulose degrading enzymes.

Tovar-Herrera OE, Martha-Paz AM, Pérez-LLano Y, Aranda E, Tacoronte-Morales JE, Pedroso-Cabrera MT, Arévalo-Niño K, Folch-Mallol JL, Batista-García RA.

Microbiologyopen. 2018 Jun;7(3):e00637. doi: 10.1002/mbo3.637. Epub 2018 May 21. Review.

11.

Anthracene drives sub-cellular proteome-wide alterations in the degradative system of Penicillium oxalicum.

Lucero Camacho-Morales R, García-Fontana C, Fernández-Irigoyen J, Santamaría E, González-López J, Manzanera M, Aranda E.

Ecotoxicol Environ Saf. 2018 Sep 15;159:127-135. doi: 10.1016/j.ecoenv.2018.04.051. Epub 2018 May 4.

PMID:
29734068
12.

Integrative multi-platform meta-analysis of gene expression profiles in pancreatic ductal adenocarcinoma patients for identifying novel diagnostic biomarkers.

Irigoyen A, Jimenez-Luna C, Benavides M, Caba O, Gallego J, Ortuño FM, Guillen-Ponce C, Rojas I, Aranda E, Torres C, Prados J.

PLoS One. 2018 Apr 4;13(4):e0194844. doi: 10.1371/journal.pone.0194844. eCollection 2018.

13.

Effect of semi-permeable cover system on the bacterial diversity during sewage sludge composting.

Robledo-Mahón T, Aranda E, Pesciaroli C, Rodríguez-Calvo A, Silva-Castro GA, González-López J, Calvo C.

J Environ Manage. 2018 Jun 1;215:57-67. doi: 10.1016/j.jenvman.2018.03.041. Epub 2018 Mar 20.

PMID:
29558651
14.

A Randomized Phase II Study of Axitinib as Maintenance Therapy After First-line Treatment for Metastatic Colorectal Cancer.

Grávalos C, Carrato A, Tobeña M, Rodriguez-Garrote M, Soler G, Vieitez JM, Robles L, Valladares-Ayerbes M, Polo E, Limón ML, Safont MJ, Martínez de Castro E, García-Alfonso P, Aranda E; Spanish Cooperative Group for the Treatment of Digestive Tumors (TTD).

Clin Colorectal Cancer. 2018 Jun;17(2):e323-e329. doi: 10.1016/j.clcc.2018.02.004. Epub 2018 Feb 17.

PMID:
29551560
15.

Degradation of bisphenol A and acute toxicity reduction by different thermo-tolerant ascomycete strains isolated from arid soils.

Mtibaà R, Olicón-Hernández DR, Pozo C, Nasri M, Mechichi T, González J, Aranda E.

Ecotoxicol Environ Saf. 2018 Jul 30;156:87-96. doi: 10.1016/j.ecoenv.2018.02.077. Epub 2018 Mar 13.

PMID:
29533211
16.

HIPECT4: multicentre, randomized clinical trial to evaluate safety and efficacy of Hyperthermic intra-peritoneal chemotherapy (HIPEC) with Mitomycin C used during surgery for treatment of locally advanced colorectal carcinoma.

Arjona-Sánchez A, Barrios P, Boldo-Roda E, Camps B, Carrasco-Campos J, Concepción Martín V, García-Fadrique A, Gutiérrez-Calvo A, Morales R, Ortega-Pérez G, Pérez-Viejo E, Prada-Villaverde A, Torres-Melero J, Vicente E, Villarejo-Campos P, Sánchez-Hidalgo JM, Casado-Adam A, García-Martin R, Medina M, Caro T, Villar C, Aranda E, Cano-Osuna MT, Díaz-López C, Torres-Tordera E, Briceño-Delgado FJ, Rufián-Peña S.

BMC Cancer. 2018 Feb 13;18(1):183. doi: 10.1186/s12885-018-4096-0.

17.

Prognostic value of primary tumour resection in synchronous metastatic colorectal cancer: Individual patient data analysis of first-line randomised trials from the ARCAD database.

van Rooijen KL, Shi Q, Goey KKH, Meyers J, Heinemann V, Diaz-Rubio E, Aranda E, Falcone A, Green E, de Gramont A, Sargent DJ, Punt CJA, Koopman M.

Eur J Cancer. 2018 Mar;91:99-106. doi: 10.1016/j.ejca.2017.12.014. Epub 2018 Jan 30.

PMID:
29353165
18.

A role for endothelial nitric oxide synthase in intestinal stem cell proliferation and mesenchymal colorectal cancer.

Peñarando J, López-Sánchez LM, Mena R, Guil-Luna S, Conde F, Hernández V, Toledano M, Gudiño V, Raponi M, Billard C, Villar C, Díaz C, Gómez-Barbadillo J, De la Haba-Rodríguez J, Myant K, Aranda E, Rodríguez-Ariza A.

BMC Biol. 2018 Jan 10;16(1):3. doi: 10.1186/s12915-017-0472-5.

19.

Personalizing Survival Predictions in Advanced Colorectal Cancer: The ARCAD Nomogram Project.

Sjoquist KM, Renfro LA, Simes RJ, Tebbutt NC, Clarke S, Seymour MT, Adams R, Maughan TS, Saltz L, Goldberg RM, Schmoll HJ, Van Cutsem E, Douillard JY, Hoff PM, Hecht JR, Tournigand C, Punt CJA, Koopman M, Hurwitz H, Heinemann V, Falcone A, Porschen R, Fuchs C, Diaz-Rubio E, Aranda E, Bokemeyer C, Souglakos I, Kabbinavar FF, Chibaudel B, Meyers JP, Sargent DJ, de Gramont A, Zalcberg JR; Fondation Aide et Recherche en Cancerologie Digestive Group (ARCAD).

J Natl Cancer Inst. 2018 Jun 1;110(6):638-648. doi: 10.1093/jnci/djx253.

PMID:
29267900
20.

Correction to: A Phase II Study Evaluating Combined Neoadjuvant Cetuximab and Chemotherapy Followed by Chemoradiotherapy and Concomitant Cetuximab in Locoregional Oesophageal Cancer Patients.

Alsina M, Rivera F, Ramos FJ, Galán M, López R, García-Alfonso P, Alés-Martinez JE, Queralt B, Antón A, Carrato A, Grávalos C, Méndez-Vidal MJ, López C, de Mena IR, Tabernero J, Giralt J, Aranda E; Spanish Cooperative Group for the Treatment of Digestive Tumors (TTD) and Grupo de Investigación Clínica en Oncología Radioterápica (GICOR).

Target Oncol. 2018 Feb;13(1):79. doi: 10.1007/s11523-017-0544-z.

PMID:
29243205
21.

Genotype-based selection of treatment of patients with advanced colorectal cancer (SETICC): a pharmacogenetic-based randomized phase II trial.

Abad A, Martínez-Balibrea E, Viéitez JM, Alonso-Orduña V, García Alfonso P, Manzano JL, Massutí B, Benavides M, Carrato A, Zanui M, Gallego J, Grávalos C, Conde V, Provencio M, Valladares-Ayerbes M, Salazar R, Sastre J, Montagut C, Rivera F, Aranda E.

Ann Oncol. 2018 Feb 1;29(2):439-444. doi: 10.1093/annonc/mdx737.

PMID:
29145602
22.

A phase II Study Evaluating Combined Neoadjuvant Cetuximab and Chemotherapy Followed by Chemoradiotherapy and Concomitant Cetuximab in Locoregional Oesophageal Cancer Patients.

Alsina M, Rivera F, Ramos FJ, Galán M, López R, García-Alfonso P, Alés-Martinez JE, Queralt B, Antón A, Carrato A, Grávalos C, Méndez-Vidal MJ, López C, de Mena IR, Tabernero J, Giralt J, Aranda E; Spanish Cooperative Group for the Treatment of Digestive Tumors (TTD) and Grupo de Investigación Clínica en Oncología Radioterápica (GICOR).

Target Oncol. 2018 Feb;13(1):69-78. doi: 10.1007/s11523-017-0536-z. Erratum in: Target Oncol. 2017 Dec 14;:.

PMID:
29128908
23.

The Relationship Between Latent Tuberculosis Infection and Acute Myocardial Infarction.

Huaman MA, Ticona E, Miranda G, Kryscio RJ, Mugruza R, Aranda E, Rondan PL, Henson D, Ticona C, Sterling TR, Fichtenbaum CJ, Garvy BA.

Clin Infect Dis. 2018 Mar 5;66(6):886-892. doi: 10.1093/cid/cix910.

PMID:
29069328
24.

Safeguarding the future of independent, academic clinical cancer research in Europe for the benefit of patients.

Negrouk A, Lacombe D, Cardoso F, Morin F, Carrasco E, Maurel J, Maibach R, Aranda E, Marais R, Stahel RA.

ESMO Open. 2017 Aug 3;2(3):e000187. doi: 10.1136/esmoopen-2017-000187. eCollection 2017.

25.

Overview on the Biochemical Potential of Filamentous Fungi to Degrade Pharmaceutical Compounds.

Olicón-Hernández DR, González-López J, Aranda E.

Front Microbiol. 2017 Sep 20;8:1792. doi: 10.3389/fmicb.2017.01792. eCollection 2017. Review.

26.

Incorporating BEAMing technology as a liquid biopsy into clinical practice for the management of colorectal cancer patients: an expert taskforce review.

García-Foncillas J, Alba E, Aranda E, Díaz-Rubio E, López-López R, Tabernero J, Vivancos A.

Ann Oncol. 2017 Dec 1;28(12):2943-2949. doi: 10.1093/annonc/mdx501. Review.

PMID:
28945877
27.

Impact of volatile composition on the sensorial attributes of dried paprikas.

Martín A, Hernández A, Aranda E, Casquete R, Velázquez R, Bartolomé T, Córdoba MG.

Food Res Int. 2017 Oct;100(Pt 1):691-697. doi: 10.1016/j.foodres.2017.07.068. Epub 2017 Aug 2.

PMID:
28873738
28.

A comparative study to evaluate natural attenuation, mycoaugmentation, phytoremediation, and microbial-assisted phytoremediation strategies for the bioremediation of an aged PAH-polluted soil.

García-Sánchez M, Košnář Z, Mercl F, Aranda E, Tlustoš P.

Ecotoxicol Environ Saf. 2018 Jan;147:165-174. doi: 10.1016/j.ecoenv.2017.08.012. Epub 2017 Sep 14.

PMID:
28843188
29.

Management of septic shock in intermediate care unit.

Meaudre E, Nguyen C, Contargyris C, Montcriol A, d'Aranda E, Esnault P, Bensalah M, Prunet B, Bordes J, Goutorbe P.

Anaesth Crit Care Pain Med. 2018 Apr;37(2):121-127. doi: 10.1016/j.accpm.2017.07.004. Epub 2017 Aug 5.

PMID:
28790011
30.

Post-hypoxia Invasion of the fetal brain by multidrug resistant Staphylococcus.

Zarate MA, Rodriguez MD, Chang EI, Russell JT, Arndt TJ, Richards EM, Ocasio BA, Aranda E, Gordon EM, Yu K, Neu J, Keller-Wood M, Triplett EW, Wood CE.

Sci Rep. 2017 Jul 25;7(1):6458. doi: 10.1038/s41598-017-06789-6.

31.

Recommendations for SIR-Spheres Y-90 resin microspheres in chemotherapy-refractory/intolerant colorectal liver metastases.

Aranda E, Aparicio J, Bilbao JI, García-Alfonso P, Maurel J, Rodríguez J, Sangro B, Vieitez JM, Feliu J.

Future Oncol. 2017 Oct;13(23):2065-2082. doi: 10.2217/fon-2017-0220. Epub 2017 Jul 13. Review.

PMID:
28703622
32.

First-line panitumumab plus FOLFOX4 or FOLFIRI in colorectal cancer with multiple or unresectable liver metastases: A randomised, phase II trial (PLANET-TTD).

Carrato A, Abad A, Massuti B, Grávalos C, Escudero P, Longo-Muñoz F, Manzano JL, Gómez A, Safont MJ, Gallego J, García-Paredes B, Pericay C, Dueñas R, Rivera F, Losa F, Valladares-Ayerbes M, González E, Aranda E; Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD).

Eur J Cancer. 2017 Aug;81:191-202. doi: 10.1016/j.ejca.2017.04.024. Epub 2017 Jun 19.

33.

Optimization of RAS/BRAF Mutational Analysis Confirms Improvement in Patient Selection for Clinical Benefit to Anti-EGFR Treatment in Metastatic Colorectal Cancer.

Santos C, Azuara D, Garcia-Carbonero R, Alfonso PG, Carrato A, Elez ME, Gomez A, Losa F, Montagut C, Massuti B, Navarro V, Varela M, Lopez-Doriga A, Moreno V, Valladares M, Manzano JL, Vieitez JM, Aranda E, Sanjuan X, Tabernero J, Capella G, Salazar R.

Mol Cancer Ther. 2017 Sep;16(9):1999-2007. doi: 10.1158/1535-7163.MCT-17-0153. Epub 2017 Jun 16.

34.

Exhaled breath condensate biomarkers for the early diagnosis of lung cancer using proteomics.

López-Sánchez LM, Jurado-Gámez B, Feu-Collado N, Valverde A, Cañas A, Fernández-Rueda JL, Aranda E, Rodríguez-Ariza A.

Am J Physiol Lung Cell Mol Physiol. 2017 Oct 1;313(4):L664-L676. doi: 10.1152/ajplung.00119.2017. Epub 2017 Jun 15.

35.

Early-Onset Ventilator-Associated Pneumonia in Patients with Severe Traumatic Brain Injury: Incidence, Risk Factors, and Consequences in Cerebral Oxygenation and Outcome.

Esnault P, Nguyen C, Bordes J, D'Aranda E, Montcriol A, Contargyris C, Cotte J, Goutorbe P, Joubert C, Dagain A, Boret H, Meaudre E.

Neurocrit Care. 2017 Oct;27(2):187-198. doi: 10.1007/s12028-017-0397-4.

PMID:
28432539
36.

The addition of celecoxib improves the antitumor effect of cetuximab in colorectal cancer: role of EGFR-RAS-FOXM1-β- catenin signaling axis.

Valverde A, Peñarando J, Cañas A, López-Sánchez LM, Conde F, Guil-Luna S, Hernández V, Villar C, Morales-Estévez C, de la Haba-Rodríguez J, Aranda E, Rodríguez-Ariza A.

Oncotarget. 2017 Mar 28;8(13):21754-21769. doi: 10.18632/oncotarget.15567.

37.

Concordance of blood- and tumor-based detection of RAS mutations to guide anti-EGFR therapy in metastatic colorectal cancer.

Grasselli J, Elez E, Caratù G, Matito J, Santos C, Macarulla T, Vidal J, Garcia M, Viéitez JM, Paéz D, Falcó E, Lopez Lopez C, Aranda E, Jones F, Sikri V, Nuciforo P, Fasani R, Tabernero J, Montagut C, Azuara D, Dienstmann R, Salazar R, Vivancos A.

Ann Oncol. 2017 Jun 1;28(6):1294-1301. doi: 10.1093/annonc/mdx112.

38.

Gemcitabine-erlotinib versus gemcitabine-erlotinib-capecitabine in the first-line treatment of patients with metastatic pancreatic cancer: Efficacy and safety results of a phase IIb randomised study from the Spanish TTD Collaborative Group.

Irigoyen A, Gallego J, Guillén Ponce C, Vera R, Iranzo V, Ales I, Arévalo S, Pisa A, Martín M, Salud A, Falcó E, Sáenz A, Manzano Mozo JL, Pulido G, Martínez Galán J, Pazo-Cid R, Rivera F, García García T, Serra O, Fernández Parra EM, Hurtado A, Gómez Reina MJ, López Gomez LJ, Martínez Ortega E, Benavides M, Aranda E; Spanish Cooperative Group of Treatment of Digestive Tumors (TTD).

Eur J Cancer. 2017 Apr;75:73-82. doi: 10.1016/j.ejca.2016.12.032. Epub 2017 Mar 7.

PMID:
28222309
39.

Early neurological wake-up test in intubated brain-injured patients: A long-term, single-centre experience.

Esnault P, Montcriol A, D'Aranda E, Bordes J, Goutorbe P, Boret H, Meaudre E.

Aust Crit Care. 2017 Sep;30(5):273-278. doi: 10.1016/j.aucc.2016.10.002. Epub 2016 Nov 14.

PMID:
27856146
40.

Identification of gene expression profiling associated with erlotinib-related skin toxicity in pancreatic adenocarcinoma patients.

Caba O, Irigoyen A, Jimenez-Luna C, Benavides M, Ortuño FM, Gallego J, Rojas I, Guillen-Ponce C, Torres C, Aranda E, Prados J.

Toxicol Appl Pharmacol. 2016 Nov 15;311:113-116. doi: 10.1016/j.taap.2016.10.003. Epub 2016 Oct 6.

PMID:
27720938
41.

Macrophage-derived extracellular vesicle-packaged WNTs rescue intestinal stem cells and enhance survival after radiation injury.

Saha S, Aranda E, Hayakawa Y, Bhanja P, Atay S, Brodin NP, Li J, Asfaha S, Liu L, Tailor Y, Zhang J, Godwin AK, Tome WA, Wang TC, Guha C, Pollard JW.

Nat Commun. 2016 Oct 13;7:13096. doi: 10.1038/ncomms13096.

42.

Fraction of Inspired Oxygen Delivered by Elisée™ 350 Turbine Transport Ventilator With a Portable Oxygen Concentrator in an Austere Environment.

d'Aranda E, Bordes J, Bourgeois B, Clay J, Esnault P, Cungi PJ, Goutorbe P, Kaiser E, Meaudre E.

J Spec Oper Med. 2016 fall;16(3):30-35.

PMID:
27734439
43.

Outcome Comparison in Children Undergoing Extracorporeal Life Support Initiated at a Local Hospital by a Mobile Cardiorespiratory Assistance Unit or at a Referral Center.

d'Aranda E, Pastene B, Ughetto F, Cotte J, Esnault P, Fouilloux V, Mazzeo C, Mancini J, Lebel S, Paut O.

Pediatr Crit Care Med. 2016 Oct;17(10):992-997.

PMID:
27705983
44.

Community structure, population dynamics and diversity of fungi in a full-scale membrane bioreactor (MBR) for urban wastewater treatment.

Maza-Márquez P, Vilchez-Vargas R, Kerckhof FM, Aranda E, González-López J, Rodelas B.

Water Res. 2016 Nov 15;105:507-519. doi: 10.1016/j.watres.2016.09.021. Epub 2016 Sep 15.

PMID:
27668995
45.

Design, syntheses, characterization, and cytotoxicity studies of novel heterobinuclear oxindolimine copper(II)-platinum(II) complexes.

Aranda EE, Matias TA, Araki K, Vieira AP, de Mattos EA, Colepicolo P, Luz CP, Marques FL, da Costa Ferreira AM.

J Inorg Biochem. 2016 Dec;165:108-118. doi: 10.1016/j.jinorgbio.2016.08.001. Epub 2016 Aug 3.

PMID:
27503192
46.

Exploring the potential of fungi isolated from PAH-polluted soil as a source of xenobiotics-degrading fungi.

Godoy P, Reina R, Calderón A, Wittich RM, García-Romera I, Aranda E.

Environ Sci Pollut Res Int. 2016 Oct;23(20):20985-20996. Epub 2016 Aug 3.

PMID:
27488713
47.

Blunt cerebrovascular injuries in severe traumatic brain injury: incidence, risk factors, and evolution.

Esnault P, Cardinale M, Boret H, D'Aranda E, Montcriol A, Bordes J, Prunet B, Joubert C, Dagain A, Goutorbe P, Kaiser E, Meaudre E.

J Neurosurg. 2017 Jul;127(1):16-22. doi: 10.3171/2016.4.JNS152600. Epub 2016 Jul 29.

PMID:
27471889
48.

Serotonin- and Dopamine-Related Gene Expression in db/db Mice Islets and in MIN6 β-Cells Treated with Palmitate and Oleate.

Cataldo LR, Mizgier ML, Busso D, Olmos P, Galgani JE, Valenzuela R, Mezzano D, Aranda E, Cortés VA, Santos JL.

J Diabetes Res. 2016;2016:3793781. doi: 10.1155/2016/3793781. Epub 2016 Jun 5.

49.

Quality Indicators to Assure and Improve Cancer Care in Spain Using the Delphi Technique.

Camps C, Albanell J, Antón A, Aranda E, Carrato A, Cassinello J, Castellano D, Cruz JJ, Garrido P, Guillem V, Grávalos C, López G, Llorente C, Lorenzo A, Lluch A, Ignacio E, Díaz-Rubio E.

J Natl Compr Canc Netw. 2016 May;14(5):553-8.

PMID:
27160233
50.

[Treating coeliac disease. How do we measure adherence to the gluten-free diet?]

Aranda EA, Araya M.

Rev Chil Pediatr. 2016 Nov - Dec;87(6):442-448. doi: 10.1016/j.rchipe.2016.01.007. Epub 2016 Feb 28. Review. Spanish.

Supplemental Content

Loading ...
Support Center